IP Library › Granted Patent US 6,881,226
Granted Patent B2
US 6,881,226 · App. 10/627,718 · Granted Apr 19, 2005

Bioabsorbable breast implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,881,226
App. No.
10/627,718
Granted
Apr 19, 2005
Kind
B2
Abstract

A breast implant has at least an outer shell which is composed of a resorbable material. The implant, which can be formed entirely of bioresorbable material such as a collagen foam, is sized and shaped to replace excised tissue. The implant supports surrounding tissue upon implantation, while allowing for in-growth of fibrous tissue to replace the implant. According to various alternative embodiments, the implant is elastically compressible, or can be formed from self-expanding foam or sponges, and can be implanted through a cannula or by injection, as well as by open procedures. The implant can carry therapeutic and diagnostic substances.

Claims (12)

1. A method for replacing excised human breast tissue with an implant comprising the steps of:

forming a cavity having surrounding tissue within a breast;

forming the implant entirely of resorbable material comprising collagen and sizing the implant to occupy the cavity; and

implanting the implant in the cavity, the implant surrounding the surrounding tissue and allowing for in-growth of fibrous tissue into and replacing the resorbable material, wherein the resorbable material is elastically compressible, and the step of implanting includes the step of compressing the resorbable material.

2. The method of claim 1 , further comprising the step of introducing into the implant at least one of a medicinal, therapeutic or diagnostic substance.

3. The method of claim 1 , wherein the at least one substance is selected from the group consisting of radiation material, antibiotics, chemotherapies, cancer therapies, hemostatic material, hormone therapies, stem cells, cellular precursors, and radiographic markers.

4. The method of claim 1 , wherein the step of implanting the implant in the cavity comprises expanding the implant within the cavity.

5. A method for replacing the excised human breast tissue with an implant comprising the steps of:

forming a cavity having surrounding tissue within a breast;

forming an implant entirely of resorbable material and sizing the implant to occupy the cavity;

implanting the implant in the cavity, the implant supporting the surrounding tissue and allowing for in-growth of fibrous tissue into and replacing the resorbable material, wherein the resorbable material is formed from a self-expanding foam and the step of implanting is performed by injection of the self-expanding foam; and

introducing into the implant at least one substance selected from the group consisting of radiation material, antibiotics, chemotherapies, cancer therapies, hemostatic material, hormone therapies, stem cells, cellular precursors, and radiographic markers.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2009
From: WHITEWATER INVESTMENTS, INC.
To: SENORX, INC.
Reel/Frame 022793/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2009
From: CORBITT, JR., JOHN D.; ANTHONY, LORI
To: WHITEWATER INVESTMENTS, INC.
Reel/Frame 022793/0591 →
Continuity (6)
Division 0982880600 · Apr 10, 2001
Continuation In Part 0916935100 · Oct 9, 1998
Provisional Application 6006158800 · Oct 10, 1997
Provisional Application 6007763900 · Mar 11, 1998
Provisional Application 6009130600 · Jun 30, 1998
Related Publication 20040049269A1 · Mar 11, 2004